探讨美托洛尔与卡维地洛治疗慢性心力衰竭的临床效果  

To Explore the Clinical Effect of Metoprolol and Carvedilol in Treatment of Chronic Heart Failure

作　　者：梁魏昉[1] 

机构地区：[1]安阳市人民医院心内二科,455000

出　　处：《中国继续医学教育》2016年第6期166-167,共2页China Continuing Medical Education

摘　　要：目的研究美托洛尔与卡维地洛治疗慢性心力衰竭的效果作用。方法选取2014年5月~2015年5月在我院接受治疗的68例慢性心力衰竭患者,随机分为对照组和实验组,每组34例,其中对照组行美托洛尔治疗,实验组行卡维地洛治疗,比较两组患者的临床疗效。结果治疗后,实验组与对照组的治疗总有效率为91.18%、70.59%,实验组总有效率高于对照组,P〈0.05;实验组LVEDd、LVESd、LVEF等心功能指标改善程度均优于对照组,P〈0.05。结论在慢性心力衰竭中运用美托洛尔与卡维地洛治疗均具有一定的疗效,但卡维地洛效果更佳,有助于患者获得更好的治疗。Objective To study the effect of the role of metoprolol and carvedilol in the treatment of chronic heart failure. Methods Selected 68 cases of chronic heart failure from May 2014 to May 2015 in our hospital, which were randomly divided during the control and experimental groups, each group had 34 cases, the control group underwent metoprolol,experiments carvedilol treatment group underwent clinical efficacy between the two groups of patients. Results After treatment, the experimental group and the control group, the total effective rate of 91.18%, 70.59%, higher than the experimental group, the total efficiency, and P〈0.05, the experimental group LVEDd, LVESd, LVEF and other indicators of the degree of improvement of cardiac function were better than the control group, P〈0.05. Conclusion The use of metoprolol in patients with chronic heart failure with carvedilol therapy has a certain effect, but carvedilol better, help patients get better treatment.

关 键 词：美托洛尔 卡维地洛 慢性心力衰竭 效果 

分 类 号：R541.61[医药卫生—心血管疾病]